- Drug Pipelines
- January 2022
- 30 Pages
Global
From €467EUR$500USD£395GBP
The Graceptor market is a segment of the immunosuppressive drug industry. Immunosuppressive drugs are used to suppress the immune system in order to prevent the body from rejecting transplanted organs or tissues. Graceptor drugs are a type of immunosuppressive drug that are used to treat autoimmune diseases, such as rheumatoid arthritis, psoriasis, and Crohn's disease. These drugs work by blocking the action of certain immune cells, which helps to reduce inflammation and prevent the body from attacking its own tissues.
The Graceptor market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly developing new drugs and treatments to meet the needs of patients with autoimmune diseases. Show Less Read more